KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $218.0 million.

  • Bausch Health Companies' Change in Receivables rose 104782.61% to $218.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $303.0 million, marking a year-over-year increase of 13129.77%. This contributed to the annual value of $216.0 million for FY2024, which is 1076.92% up from last year.
  • Latest data reveals that Bausch Health Companies reported Change in Receivables of $218.0 million as of Q3 2025, which was up 104782.61% from $91.0 million recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' Change in Receivables peaked at $231.0 million during Q3 2023, and registered a low of -$197.0 million during Q1 2022.
  • In the last 5 years, Bausch Health Companies' Change in Receivables had a median value of $63.0 million in 2024 and averaged $47.2 million.
  • Examining YoY changes over the last 5 years, Bausch Health Companies' Change in Receivables showed a top increase of 104782.61% in 2025 and a maximum decrease of 27460.32% in 2025.
  • Quarter analysis of 5 years shows Bausch Health Companies' Change in Receivables stood at $52.0 million in 2021, then plummeted by 40.38% to $31.0 million in 2022, then tumbled by 38.71% to $19.0 million in 2023, then soared by 447.37% to $104.0 million in 2024, then soared by 109.62% to $218.0 million in 2025.
  • Its last three reported values are $218.0 million in Q3 2025, $91.0 million for Q2 2025, and -$110.0 million during Q1 2025.